ATE225806T1 - D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet - Google Patents
D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaetInfo
- Publication number
- ATE225806T1 ATE225806T1 AT95932735T AT95932735T ATE225806T1 AT E225806 T1 ATE225806 T1 AT E225806T1 AT 95932735 T AT95932735 T AT 95932735T AT 95932735 T AT95932735 T AT 95932735T AT E225806 T1 ATE225806 T1 AT E225806T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- alkyltryptophane
- hormone releasing
- containing polypeptides
- releasing activity
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title 1
- 230000003578 releasing effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- BXJSOEWOQDVGJW-SNVBAGLBSA-N (2r)-2-azaniumyl-3-(2-methyl-1h-indol-3-yl)propanoate Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=C(C)NC2=C1 BXJSOEWOQDVGJW-SNVBAGLBSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI941954A IT1270021B (it) | 1994-09-27 | 1994-09-27 | "composti polipeptidici contenenti d-2-metiltriptofano aventi attivita'sull'aumento del camp intracellulare" |
| IT95MI001293A IT1276734B1 (it) | 1995-06-16 | 1995-06-16 | Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della |
| PCT/EP1995/003601 WO1996010040A1 (en) | 1994-09-27 | 1995-09-13 | Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE225806T1 true ATE225806T1 (de) | 2002-10-15 |
Family
ID=26331189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95932735T ATE225806T1 (de) | 1994-09-27 | 1995-09-13 | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5795957A (de) |
| EP (1) | EP0783521B8 (de) |
| JP (1) | JP3810083B2 (de) |
| KR (1) | KR100369105B1 (de) |
| CN (1) | CN1121413C (de) |
| AT (1) | ATE225806T1 (de) |
| AU (1) | AU700066B2 (de) |
| CA (1) | CA2201122A1 (de) |
| CZ (1) | CZ291798B6 (de) |
| DE (1) | DE69528531T2 (de) |
| DK (1) | DK0783521T3 (de) |
| ES (1) | ES2186730T3 (de) |
| HK (1) | HK1001207A1 (de) |
| HU (1) | HU221481B (de) |
| IL (1) | IL115381A (de) |
| MX (1) | MX9702275A (de) |
| PL (1) | PL181588B1 (de) |
| PT (1) | PT783521E (de) |
| RU (1) | RU2157378C2 (de) |
| SK (1) | SK284550B6 (de) |
| WO (1) | WO1996010040A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| US20020111461A1 (en) | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
| IT1277113B1 (it) * | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
| WO1999039730A1 (fr) * | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Preparation a administration orale contenant des peptides favorisant la secretion d'hormone de croissance |
| US5932548A (en) * | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
| US6696063B1 (en) | 1998-12-30 | 2004-02-24 | Applied Research Systems Ars Holding N.V. | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy |
| US6211156B1 (en) * | 1999-11-10 | 2001-04-03 | Asta Medica A.G. | Peptides for treatment of erectile dysfunction |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| WO2006078320A2 (en) | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
| GB0603295D0 (en) | 2006-02-18 | 2006-03-29 | Ardana Bioscience Ltd | Methods and kits |
| EP2222281B1 (de) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
| US4411890A (en) * | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228156A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228155A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223021A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4224316A (en) * | 1979-03-30 | 1980-09-23 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4226857A (en) * | 1979-03-30 | 1980-10-07 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228157A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228158A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223020A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223019A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| JPS58501861A (ja) * | 1981-12-28 | 1983-11-04 | ベツクマン・インストルメンツ・インコ−ポレ−テツド | 下垂体成長ホルモン放出活性を有する合成ペプチド |
| US4410513A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4410512A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
| US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| AU637316B2 (en) * | 1988-01-28 | 1993-05-27 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| DE3915361A1 (de) * | 1989-05-11 | 1990-11-15 | Merck Patent Gmbh | Cyclopeptide |
| IT1240643B (it) * | 1990-05-11 | 1993-12-17 | Mediolanum Farmaceutici Spa | Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano |
| EP0663834A4 (de) * | 1992-09-25 | 1996-01-24 | Smithkline Beecham Corp | Wachstumshormon freisetzende peptide. |
-
1995
- 1995-09-13 HU HU9800136A patent/HU221481B/hu not_active IP Right Cessation
- 1995-09-13 WO PCT/EP1995/003601 patent/WO1996010040A1/en active IP Right Grant
- 1995-09-13 ES ES95932735T patent/ES2186730T3/es not_active Expired - Lifetime
- 1995-09-13 KR KR1019970701987A patent/KR100369105B1/ko not_active IP Right Cessation
- 1995-09-13 PT PT95932735T patent/PT783521E/pt unknown
- 1995-09-13 RU RU97107089/04A patent/RU2157378C2/ru not_active IP Right Cessation
- 1995-09-13 CZ CZ1997914A patent/CZ291798B6/cs not_active IP Right Cessation
- 1995-09-13 PL PL95319382A patent/PL181588B1/pl unknown
- 1995-09-13 MX MX9702275A patent/MX9702275A/es not_active IP Right Cessation
- 1995-09-13 AU AU35668/95A patent/AU700066B2/en not_active Ceased
- 1995-09-13 JP JP51131596A patent/JP3810083B2/ja not_active Expired - Fee Related
- 1995-09-13 DE DE69528531T patent/DE69528531T2/de not_active Expired - Fee Related
- 1995-09-13 SK SK399-97A patent/SK284550B6/sk unknown
- 1995-09-13 EP EP95932735A patent/EP0783521B8/de not_active Expired - Lifetime
- 1995-09-13 DK DK95932735T patent/DK0783521T3/da active
- 1995-09-13 CN CN95195323A patent/CN1121413C/zh not_active Expired - Fee Related
- 1995-09-13 AT AT95932735T patent/ATE225806T1/de not_active IP Right Cessation
- 1995-09-13 CA CA002201122A patent/CA2201122A1/en not_active Abandoned
- 1995-09-20 US US08/530,853 patent/US5795957A/en not_active Expired - Fee Related
- 1995-09-21 IL IL11538195A patent/IL115381A/xx not_active IP Right Cessation
-
1998
- 1998-01-02 HK HK98100002A patent/HK1001207A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL115381A0 (en) | 1995-12-31 |
| CN1121413C (zh) | 2003-09-17 |
| ES2186730T3 (es) | 2003-05-16 |
| IL115381A (en) | 2000-07-16 |
| CZ91497A3 (en) | 1997-09-17 |
| KR100369105B1 (ko) | 2003-04-07 |
| JPH10506114A (ja) | 1998-06-16 |
| SK39997A3 (en) | 1997-09-10 |
| EP0783521A1 (de) | 1997-07-16 |
| RU2157378C2 (ru) | 2000-10-10 |
| JP3810083B2 (ja) | 2006-08-16 |
| AU700066B2 (en) | 1998-12-17 |
| HUT77525A (hu) | 1998-05-28 |
| PL181588B1 (pl) | 2001-08-31 |
| DE69528531D1 (de) | 2002-11-14 |
| AU3566895A (en) | 1996-04-19 |
| SK284550B6 (sk) | 2005-06-02 |
| US5795957A (en) | 1998-08-18 |
| CZ291798B6 (cs) | 2003-05-14 |
| DK0783521T3 (da) | 2003-01-27 |
| PL319382A1 (en) | 1997-08-04 |
| HK1001207A1 (en) | 1998-06-05 |
| EP0783521B1 (de) | 2002-10-09 |
| KR970706305A (ko) | 1997-11-03 |
| WO1996010040A1 (en) | 1996-04-04 |
| MX9702275A (es) | 1997-06-28 |
| DE69528531T2 (de) | 2003-06-05 |
| HU221481B (en) | 2002-10-28 |
| PT783521E (pt) | 2003-02-28 |
| EP0783521B8 (de) | 2003-04-09 |
| CN1158622A (zh) | 1997-09-03 |
| CA2201122A1 (en) | 1996-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
| NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
| DE69703449D1 (de) | Neuroaktive peptide | |
| DE69837264D1 (de) | Dipeptidderivate zur förderung der sekretion von wachstumshormon | |
| DE69732871D1 (de) | Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung | |
| AU1750297A (en) | Humanized green fluorescent protein genes and methods | |
| ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
| DE60030450D1 (de) | Von MUC-1 abgeleitete Peptide | |
| TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
| DK1129186T3 (da) | Et faktor VIII-polypeptid med faktor VIII:C-aktivitet | |
| EP0875567A3 (de) | Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung | |
| DK148085C (da) | Dipeptidet pyrglu-his(2,4-dinitrophenyl)-oh og fremgangsmaade til fremstilling af lh-rh og lh-rh-analoge peptider under anvendelse af dette dipeptid | |
| ES2087337T3 (es) | Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos. | |
| MX169334B (es) | Preparacion de liberacion sostenida | |
| ATE93527T1 (de) | Peptide und deren benutzung. | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| NO891926D0 (no) | Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater. | |
| DE3869939D1 (de) | Biologisch wirksame peptide. | |
| GB9604518D0 (en) | Novel compounds | |
| DE69030316D1 (de) | Schrittweiser c-terminaler abbau von peptiden und proteinen | |
| DE68914057D1 (de) | Peptide. | |
| DE60044468D1 (de) | Herstellung von sekretierten polypeptiden | |
| NO893572L (no) | Lunge-overflateaktivt protein og beslektet polypeptid. | |
| ATE81531T1 (de) | Biologisch aktive peptide tan-866. | |
| IT8847737A0 (it) | Procedimento per ottenere amminoacidi da sostanze proteiche per uso fertilizzante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0783521 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |